BCG vaccine produce BCG. Along with supply availability from existing manufacturers, and a "new WHO prequalified vaccine" the total supply will be "sufficient to meet both suppressed 2015 demand carried over to 2016, as well as total forecast demand through 2016-2018." In the fall of 2011, the Sanofi Pasteur plant flooded causing problems with mold. The facility, located in Toronto, Ontario, Canada, produced BCG vaccine products, made with substrain Connaught, such as a tuberculosis vaccine ImmuCYST, a BCG Immunotherapeutic – a bladder cancer drug. By April 2012 the FDA had found dozens of documented problems with sterility at the plant including mold,
Inoculation theory to back that idea up. There are also scholars on the other side who suggest that too much of a delay lessens the strengthening effect of inoculation. With this being said, it has been revealed that the effect of inoculation can still be significant weeks or even months after initial introduction or the treatment showing that it does produce somewhat long-lasting effects (Banas & Rains, 2010). Involvement is the final element of the inoculation process. Pfau, et al. (1997a) defined involvement as "the importance or salience of an attitude object for a receiver" and is “among the most important and